Metraipolis › archive › dc_4a322772df99

Comparative characteristics of homocysteine and uric acid in patients with Parkinson's disease-related cognitive impairment and post-stroke cognitive impairment — Europe PMC PMID:42111071

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42111071
DOI
10.3389/fneur.2026.1819930
License (as archived)
solo-consultazione
Archived
2026-10-17T10:35:29.682Z
SHA-256 of the archived text
ad2ca816ca1cae0fe6aad71f6ced7253f7216f612351b05bf2f8f48df2108c67
Stable URL of this page
https://metraipolis.com/documento/dc_4a322772df99

How to cite

Comparative characteristics of homocysteine and uric acid in patients with Parkinson's disease-related cognitive impairment and post-stroke cognitive impairment — Europe PMC PMID:42111071 — Europe PMC (en), https://europepmc.org/article/MED/42111071 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4a322772df99 (Metraipolis archive dc_4a322772df99, sha256 ad2ca816ca1cae0fe6aad71f6ced7253f7216f612351b05bf2f8f48df2108c67)
BibTeX
@misc{dc4a322772df99,
  title = {Comparative characteristics of homocysteine and uric acid in patients with Parkinson's disease-related cognitive impairment and post-stroke cognitive impairment — Europe PMC PMID:42111071},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42111071},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4a322772df99; sha256 ad2ca816ca1cae0fe6aad71f6ced7253f7216f612351b05bf2f8f48df2108c67},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42111071. Agents can read the archived copy with the MCP tool read_document.